BINA Trademark

Trademark Overview


On Tuesday, July 7, 2015, a trademark application was filed for BINA with the United States Patent and Trademark Office. The USPTO has given the BINA trademark a serial number of 86685779. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 13, 2023. This trademark is owned by Roche Molecular Systems, Inc.. The BINA trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

Downloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; downloadable computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, bio marker information; computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software

Data collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely, of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to individuals' clinical responses to drug treatments and treatment regimes; providing scientific advise in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of ...
bina

General Information


Serial Number86685779
Word MarkBINA
Filing DateTuesday, July 7, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 13, 2023
Registration Number4986651
Registration DateTuesday, June 28, 2016
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 12, 2016

Trademark Statements


Description of MarkThe mark consists of the stylized wording "BINA".
Goods and ServicesDownloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; downloadable computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, bio marker information; computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "BINA" has no meaning in a foreign language.
Goods and ServicesData collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely, of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to individuals' clinical responses to drug treatments and treatment regimes; providing scientific advise in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients, providing scientific information on individuals' genomic changes that contribute to a unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; providing an on-line searchable database in the field of clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information and bio marker information for scientific research purposes

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 13, 2023
Primary Code009
First Use Anywhere DateThursday, October 30, 2014
First Use In Commerce DateThursday, October 30, 2014

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 13, 2023
Primary Code042
First Use Anywhere DateThursday, October 30, 2014
First Use In Commerce DateThursday, October 30, 2014

Trademark Owner History


Party NameRoche Molecular Systems, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Party NameRoche Molecular Systems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Party NameRoche Molecular Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Trademark Events


Event DateEvent Description
Friday, January 13, 2023CANCELLED SEC. 8 (6-YR)
Monday, June 28, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 19, 2020TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, October 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 27, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 27, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 2, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 2, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 28, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, April 12, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2016NOTICE OF PUBLICATION
Friday, March 4, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 4, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 24, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 24, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 16, 2016ASSIGNED TO LIE
Monday, February 8, 2016ASSIGNED TO LIE
Friday, January 29, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 3, 2015NON-FINAL ACTION MAILED
Wednesday, September 2, 2015NON-FINAL ACTION WRITTEN
Monday, August 31, 2015ASSIGNED TO EXAMINER
Friday, July 10, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 10, 2015NEW APPLICATION ENTERED